Skip to main navigation Skip to search Skip to main content
20072025

Research activity per year

Personal profile

Biography

Professor Graham Mann is Director of the John Curtin School of Medical Research, Australian National University, and a principal investigator at Melanoma Institute Australia, University of Sydney. He co-leads a highly translational research program on melanoma supported by NHMRC Program and Centre for Research Excellence grants. This program is engaged in all aspects of melanoma control, from the genetics of melanoma risk and its environmental and psychological aspects, to the use of molecular markers and targets to improve the diagnosis and treatment of melanoma. As co-PI of the Australian Melanoma Genome Project he is a member of the Scientific Steering Committee of the International Cancer Genome Consortium (ICGC). He holds project/program grants worth $5.6m for 2019, $3.8m as CI-A or program co-PI. With a H-index of 47 his 210 primary research papers, excluding a further 38 authored as part of large consortia, have been cited more than 8,500 times.

  • 2017 NSW Premier’s Award for Excellence in Translational Cancer Research
  • 2014 NSW Premier’s Wildfire Award for highly-cited research
  • Professor J A Young Medal 2010 for excellence in research and service to the University of Sydney
  • 2009 NSW Premier’s Award for Excellence in Translational Cancer Research
  • RACP Roche Fellowship 1987
  • University of Sydney Medical Foundation Scholarship 1987-8
  • Charles Gilbert Heydon Travelling Fellowship in the Biological Sciences 1987-8

Qualifications

MBBS PhD FRACP

Fingerprint

Dive into the research topics where Graham Mann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Find out about recent ANU collaborations across the world by selecting a location on the map OR
  • Correction: Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance

    Newell, F., Pires da Silva, I., Johansson, P. A., Menzies, A. M., Wilmott, J. S., Addala, V., Carlino, M. S., Rizos, H., Nones, K., Edwards, J. J., Lakis, V., Kazakoff, S. H., Mukhopadhyay, P., Ferguson, P. M., Leonard, C., Koufariotis, L. T., Wood, S., Blank, C. U., Thompson, J. F. & Spillane, A. J. & 8 others, Saw, R. P. M., Shannon, K. F., Pearson, J. V., Mann, G. J., Hayward, N. K., Scolyer, R. A., Waddell, N. & Long, G. V., 10 Mar 2025, In: Cancer Cell. 43, 3, p. 563 1 p.

    Research output: Contribution to journalComment/debatepeer-review

  • Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

    the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer, the Risk Factor Analysis of Hereditary Breast and Ovarian Cancer Study, the Basser Center University of Pennsylvania Registry & the Breast Cancer Family Registry, 1 Feb 2025, In: Journal of Clinical Oncology. 43, 4, p. 422-431 15 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    13 Citations (Scopus)
  • Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

    NBCS Collaborators & kConFab Investigators, 5 Sept 2024, In: American Journal of Human Genetics. 111, 9, p. 2059-2069 11 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    6 Citations (Scopus)
  • DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

    Conway, K., Edmiston, S. N., Vondras, A., Reiner, A., Corcoran, D. L., Shen, R., Parrish, E. A., Hao, H., Lin, L., Kenney, J. M., Ilelaboye, G., Kostrzewa, C. E., Kuan, P. F., Busam, K. J., Lezcano, C., Lee, T. K., Hernando, E., Googe, P. B., Ollila, D. W. & Moschos, S. & 107 others, Gorlov, I., Amos, C. I., Ernstoff, M. S., Cust, A. E., Wilmott, J. S., Scolyer, R. A., Mann, G. J., Vergara, I. A., Ko, J., Rees, J. R., Yan, S., Nagore, E., Bosenberg, M., Rothberg, B. G., Osman, I., Lee, J. E., Saenger, Y., Bogner, P., Thompson, C. L., Gerstenblith, M., Holmen, S. L., Funchain, P., Brunsgaard, E., Depcik-Smith, N. D., Luo, L., Boyce, T., Orlow, I., Begg, C. B., Berwick, M., Thomas, N. E., Berwick, M., Luo, L., Boyce, T. W., Reynolds, A. Z., Wiggins, C., Thomas, N. E., Conway, K., Edmiston, S. N., Ollila, D. W., Hao, H., Parrish, E., Googe, P. B., Moschos, S. J., Corcoran, D., Vondras, A., Tsai, Y. S., Lin, L., Shen, R., Begg, C. B., Arora, A., Seshan, V., Reiner, A., Kostrzewa, C. E., Busam, K. J., Orlow, I., Lezcano, C., Kenney, J. M., Sadeghi, K. D., O'connell, K., Ilelaboye, G. E., Parmar, H., Leong, S., Corrales, S., Scolyer, R. A., Cust, A. E., Wilmott, J. S., Mann, G. J., Shang, P., Burke, H., Ferguson, P. M., Jakrot, V., Lee, T. K., Hernando, E., Osman, I., Hanniford, D., Argibay, D., Moran, U., Heguy, A., Ramaswami, S., Amos, C. I., Gorlov, I. P., Zhu, D., Ernstoff, M., Bogner, P. N., Lee, J. E., Rees, J. R., Yan, S., Gerstenblith, M. R., Thompson, C., Ko, J. S., Funchain, P., Ngo, P., Bosenberg, M., Gould Rothberg, B. E., Panse, G., Saenger, Y. M., Fullerton, B. T., Holmen, S. L., Colman, H., Brunsgaard, E. K., Wada, D., Nagore, E., Manrique-Silva, E., Requena, C., Traves, V., Millan-Esteban, D. & Rainka, M., 1 Nov 2024, In: JCO Precision Oncology. 8, 00375.

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)
  • Follow-up assessment of sleep-related symptoms in patients after treatment for cancer: responses to continuous positive airway pressure treatment for co-morbid obstructive sleep apnoea

    Subramanian, H., Trivedi, R., Fuchsova, V., Elder, E., Brand, A., Howle, J., Mann, G. J., DeFazio, A., Amis, T. & Kairaitis, K., May 2024, In: Sleep and Breathing. 28, 2, p. 725-733 10 p.

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)